Get in contact with out sales team using the form below
Scantox is a GLP-accredited pre-clinical contract research organization originally founded in 1977. Since 2021 Scantox is owned by the Nordic based investment company Impilo. Our focus is on providing high quality work within pharmacology, toxicology and histopathology. We service both global and local partners and are considered world leading within minipig toxicology.